Concepedia

Yves Leestemaker

YL

5

Publications

614

Citations

5

H-Index

2012

Active since

Affiliations

Leiden University Medical Center(Current)

The Netherlands Cancer Institute

Utrecht University

University of California San Diego

Oncode Institute

Yves Leestemaker is an author at Leiden University Medical Center specializing in medicine, biochemistry, and proteomics.

Top concepts

Publications per year

2012–2019

5

Publications

5

Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons

Rik van der Kant, Vanessa F. Langness, Cheryl Herrera et al. · Cell stem cell · 2019 · 356 citations · Full text

Proteasome Activation by Small Molecules

Yves Leestemaker, Annemieke de Jong, Katharina F. Witting et al. · Cell chemical biology · 2017 · 143 citations · Full text

, , +8

Probing the Specificity and Activity Profiles of the Proteasome Inhibitors Bortezomib and Delanzomib

Celia R. Berkers, Yves Leestemaker, Karianne Schuurman et al. · Molecular Pharmaceutics · 2012 · 51 citations

, , +21

Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specification

Christella E. Widjaja, Jocelyn G. Olvera, Patrick J Metz et al. · Journal of Clinical Investigation · 2017 · 49 citations · Full text

Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation

Amy L. Palmer, Annemieke de Jong, Yves Leestemaker et al. · The Journal of Immunology · 2017 · 15 citations · Full text

Rows per page

1–5 of 5